Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 1475 entries
View as:

Observational Study for Lung Cancer Patients Treated With Nivolumab

Phase: N/A Priority: Normal
NCT ID: NCT03382496 Org: User:
Start: 10/01/16 End: 12/23/20 Due: 12/23/21

Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00651508 Org: User:
Start: 04/30/08 End: 10/31/08 Due: 10/31/09

A Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02293629 Org: User:
Start: 10/31/14 End: 11/30/14 Due: 11/30/15

A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06024174 Org: User:
Start: 11/09/23 End: 05/13/24 Due: 05/13/25

A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT02161939 Org: User:
Start: - End: - Due: -

A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan

Phase: N/A Priority: Normal
NCT ID: NCT04043975 Org: User:
Start: 09/19/19 End: 08/23/24 Due: 08/23/25

A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02902679 Org: User:
Start: 11/30/16 End: 06/30/17 Due: 06/30/18

Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01492374 Org: User:
Start: 02/29/12 End: 10/31/13 Due: 10/31/14

Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics

Phase: N/A Priority: Normal
NCT ID: NCT01166620 Org: User:
Start: 06/30/10 End: 03/31/12 Due: 03/31/13

A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring

Phase: N/A Priority: Normal
NCT ID: NCT05170126 Org: User:
Start: 08/08/22 End: 06/30/32 Due: 06/30/33

An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO®) in Combination With Platinum-Based Chemotherapy in Non-Metastatic Non-Small Cell Lung Cancer Participants in Germany

Phase: N/A Priority: Normal
NCT ID: NCT06169956 Org: User:
Start: 11/30/23 End: 09/30/30 Due: 09/30/31

Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01489059 Org: User:
Start: 12/31/11 End: 06/30/14 Due: 06/30/15

A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus

Phase: N/A Priority: Normal
NCT ID: NCT05034926 Org: User:
Start: 10/07/20 End: 09/15/25 Due: 09/15/26

Japanese Bridging Study Conducted in the United States

Phase: N/A Priority: Normal
NCT ID: NCT00947245 Org: User:
Start: 10/31/14 End: 02/28/15 Due: 02/28/16

A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05165264 Org: User:
Start: 02/16/22 End: 12/31/26 Due: 12/31/27

A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.

Phase: N/A Priority: Normal
NCT ID: NCT05567458 Org: User:
Start: 10/17/22 End: 08/01/26 Due: 08/01/27

A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT06112743 Org: User:
Start: 01/24/24 End: 07/31/26 Due: 07/31/27

Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus

Phase: N/A Priority: Normal
NCT ID: NCT00410202 Org: User:
Start: 03/31/08 End: 07/31/12 Due: 07/31/13

A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany

Phase: N/A Priority: Normal
NCT ID: NCT06104644 Org: User:
Start: 04/13/23 End: 05/31/30 Due: 05/31/31

A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)

Phase: N/A Priority: Normal
NCT ID: NCT04008030 Org: User:
Start: 08/05/19 End: 06/10/26 Due: 06/10/27

Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03114163 Org: User:
Start: 05/12/17 End: 04/28/25 Due: 04/28/26

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT06979453 Org: User:
Start: 08/26/25 End: 08/12/34 Due: 08/12/35

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

Phase: N/A Priority: Normal
NCT ID: NCT06875960 Org: User:
Start: 03/17/25 End: 12/01/26 Due: 12/01/27

A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02985632 Org: User:
Start: 01/11/17 End: 07/07/17 Due: 07/07/18

A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03336216 Org: User:
Start: 12/18/17 End: 06/01/23 Due: 06/01/24